More patients are getting their meds online. Big Pharma wants in on the action; At health care’s biggest investor conference, AI’s high hopes collided with skepticism

Taking stock of the drug industry, from the lab to the medicine chest

January 17, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Mike Reddy for STAT STAT+ | More patients are getting their meds online. Big Pharma wants in on the action A partnership between LillyDirect and online pharmacy Truepill becomes an industry model, as drugmakers expand direct-to-consumer marketing. By Katie Palmer STAT+ | At health care's biggest investor conference, AI's high hopes collided with skepticism Generative AI was prominently featured at the J.P. Morgan Healthcare Conference, but not everybody was convinced of its near-term value. By Casey Ross and Matthew Herper and Mohana Ravindranath STAT+ | Copay coupons for some drugs must count toward deductibles, after Biden court move Biden drops defense of Trump copay accumulator rule that aimed to curb drug prices but raised patient costs. By John Wilkerson Adobe STAT+ | Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it Though in early stages, an antibody being developed by Perseus Therapeutics shows promise in preventing this common chemotherapy side effect. By Angus Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser